Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,034 | 668 | 683 | 937 | 566 |
| Gross Profit | 1,034 | 668 | 683 | 937 | 566 |
| Operating Expenses | 44,649 | 46,835 | 38,517 | 45,284 | 32,579 |
| Operating Income | -43,615 | -46,167 | -37,834 | -44,347 | -32,013 |
| Other Income | 3,024 | 3,708 | 4,086 | 4,381 | 4,743 |
| Pre-tax Income | -40,591 | -42,459 | -33,748 | -39,966 | -27,270 |
| Net Income Continuous | -40,591 | -42,459 | -33,748 | -39,966 | -27,270 |
| Net Income | $-40,591 | $-42,459 | $-33,748 | $-39,966 | $-27,270 |
| EPS Basic Total Ops | -0.75 | -0.78 | -0.63 | -0.74 | -0.51 |
| EPS Basic Continuous Ops | -0.75 | -0.79 | -0.63 | -0.74 | -0.51 |
| EPS Diluted Total Ops | -0.75 | -0.78 | -0.63 | -0.74 | -0.51 |
| EPS Diluted Continuous Ops | -0.75 | -0.79 | -0.63 | -0.74 | -0.51 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.79 | -0.63 | -0.74 | -0.51 |
| EBITDA(a) | $-44,320 | $-44,738 | $-37,942 | $-45,290 | $-33,705 |